Literature DB >> 22048569

[Advance directives in patients with mental disorders. Scope, prerequisites for validity, and clinical implementation].

J Vollmann1.   

Abstract

Since 1 September 2009, advance directives are regulated by law in Germany. This article discusses ethical challenges of advance directives in patients with mental disorders. Besides concrete information on the preferred medical treatment in concrete clinical situations, the mental capacity of the patient at the time of issuing the directive is essential. The "Decisional Competence Assessment Tool for Psychiatric Advance Directives" and empirical studies from the USA on advance directives in patients with mental disorders and the assessment by the treating psychiatrists of these patient directives are discussed. Ethical conclusions are drawn for handling advance directives in psychiatric practice.

Entities:  

Mesh:

Year:  2012        PMID: 22048569     DOI: 10.1007/s00115-011-3407-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  18 in total

Review 1.  [Advance directives in clinical practice].

Authors:  J Vollmann; I Knöchel-Schiffer
Journal:  Med Klin (Munich)       Date:  1999-07-15

2.  [Mental competence and neuropsychologic impairments in demented patients].

Authors:  J Vollmann; K-P Kühl; A Tilmann; H D Hartung; H Helmchen
Journal:  Nervenarzt       Date:  2003-05-10       Impact factor: 1.214

3.  Law & psychiatry: psychiatric advance directives and the treatment of committed patients.

Authors:  Paul S Appelbaum
Journal:  Psychiatr Serv       Date:  2004-07       Impact factor: 3.084

4.  Discussing living wills. A qualitative study of a German sample of neurologists and ALS patients.

Authors:  Nicole Burchardi; Oliver Rauprich; Martin Hecht; Marcus Beck; Jochen Vollmann
Journal:  J Neurol Sci       Date:  2005-10-15       Impact factor: 3.181

5.  [Patient's advance directives and appointment of a health-care proxy in elderly psychiatric patients].

Authors:  M Haupt; H Seeber; M Jänner
Journal:  Nervenarzt       Date:  1999-03       Impact factor: 1.214

6.  Competence to complete psychiatric advance directives: effects of facilitated decision making.

Authors:  Eric B Elbogen; Jeffrey W Swanson; Paul S Appelbaum; Marvin S Swartz; Joelle Ferron; Richard A Van Dorn; H Ryan Wagner
Journal:  Law Hum Behav       Date:  2007-06

7.  Facilitated psychiatric advance directives: a randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness.

Authors:  Jeffrey W Swanson; Marvin S Swartz; Eric B Elbogen; Richard A Van Dorn; Joelle Ferron; H Ryan Wagner; Barbara J McCauley; Mimi Kim
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

8.  Stability of preferences for end-of-life treatment after 3 years of follow-up: the Johns Hopkins Precursors Study.

Authors:  Marsha N Wittink; Knashawn H Morales; Lucy A Meoni; Daniel E Ford; Nae-Yuh Wang; Michael J Klag; Joseph J Gallo
Journal:  Arch Intern Med       Date:  2008-10-27

9.  Advance directives. Stability of patients' treatment choices.

Authors:  L L Emanuel; E J Emanuel; J D Stoeckle; L R Hummel; M J Barry
Journal:  Arch Intern Med       Date:  1994-01-24

10.  [The problem of performing medical procedures without informed consent in unconscious patients].

Authors:  H-C Hansen; R Drews; P W Gaidzik
Journal:  Nervenarzt       Date:  2008-06       Impact factor: 1.214

View more
  3 in total

1.  [Compulsory treatment in psychiatry: an ethical analysis of the new legal regulations for clinical practice].

Authors:  J Vollmann
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

Review 2.  [Advance directive of probands in pharmaceutical research : A medical ethics discussion].

Authors:  M Haupt; F Jessen; H Fangerau
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

Review 3.  [Compulsory treatment under legal uncertainty: part 2: consequences of legal uncertainty in clinical practice - suggestions for improvement].

Authors:  S Müller; H Walter; H Kunze; N Konrad; A Heinz
Journal:  Nervenarzt       Date:  2012-09       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.